GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Sale Of Property, Plant, Equipment

Roivant Sciences (STU:87S) Sale Of Property, Plant, Equipment : €0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Sale Of Property, Plant, Equipment?

Roivant Sciences's sale of property, plant, equipment for the three months ended in Sep. 2024 was €0.0 Mil. It means Roivant Sciences gained €0.0 Mil from selling property, plant, and equipment. Roivant Sciences's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Jun. 2024 ), Roivant Sciences gained the same money from selling property, plant, and equipment in Sep. 2024 (€0.0 Mil).


Roivant Sciences Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Roivant Sciences's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Sale Of Property, Plant, Equipment Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Sale Of Property, Plant, Equipment
- - - -

Roivant Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Roivant Sciences Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roivant Sciences Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Roivant Sciences Business Description

Industry
Traded in Other Exchanges
Address
50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines